IL TEST ECO-DOBUTAMINA NELLA VALUTAZIONE A BREVE TERMINE DEI RISULTATI DELL'ANGIOPLASTICA CORONARICA

Translated title of the contribution: Dobutamine echocardiography in the short-term evaluation of PTCA results

L. Lanzarini, R. Fetiveau, M. Previtali, A. Poli, A. Mussini, M. Ferrario, E. Bramucci, C. Montemartini

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background. Coronary angioplasty is commonly performed as a means of coronary revascularization, but at present no method has proven to be of definite value in assessing the functional result of a given angiographic procedure. Objectives. The purpose of this study was to evaluate whether dobutamine stress echocardiography can detect a reversal of ischemia-induced left ventricular regional wall motion abnormalities 15 days after an angiographically successful percutaneous transluminal coronary angioplasty (PTCA). Methods. 25 patients underwent dobutamine stress echocardiography 24-48 hours before and 15 days after an elective angiographically successful PTCA. Twelve out of 25 patients (48%) suffered from a previous myocardial infarction. Symptomatic myocardial ischemia was documented before PTCA in 18/25 patients (72%) and asymptomatic ischemia in 7/25 (28%). Dobutamine was infused utilizing incremental steps of 5 mcg/kg/min over 3 minutes, up to a maximal dose of 40 mcg/kg/min. Echocardiographic images were stored on video tape and analyzed in a qualitative manner by two independent and experienced cardiologists without knowledge of the angiographic data. An asynergy score (from 0 = normal to 3 = diskinesia) was calculated using a 14-segment left ventricular model in basal conditions and at peak stress, before and after PTCA. All tests were performed taking the patients off the antianginal therapy. Results. One-vessel coronary artery disease was present in 18/25 (72%) patients, and two-vessel disease in 7/25 (28%) four of these 7 patients underwent PTCA on both involved vessels; mean diameter of the stenosis was 91 ± 6% before PTCA, and was reduced to 22 ± 8% after PTCA. Dobutamine stress echocardiography induced wall motion abnormalities in 24/25 patients before and in 4/25 after PTCA; the frequency of dobutamine-induced wall motion abnormalities significantly decreased from 96% to 12% before and after angioplasty (p <.01). All patients developed regional wall motion abnormalities in the region supplied by the dilated vessel. Wall motion score at peak dobutamine infusion improved from 8.5 ± 4.8 before PTCA to 2.6 ± 4.9 after PTCA (p <.001). There was a significant increase in the rate-pressure product achieved during the test after PTCA (21300 ± 400 bts/min.mmHg) compared to the test performed before PTCA (19000 ± 500 bts/min.mmHg) (p <.05). Dobutamine induced angina in 6/26 patients (24%) and ST-segment changes in 19/25 patients (76%) before PTCA, whereas angina occurred only once after PTCA and ST-segment changes 6 times only after PTCA. No major side effects occurred during dobutamine infusion both before and after PTCA. Conclusions. Our study indicates that dobutamine stress echocardiography is a feasible and safe method that accurately demonstrates an early improvement in stress-induced regional left ventricular dysfunction after an angiogrphically successful coronary angioplasty.

Original languageItalian
Pages (from-to)107-114
Number of pages8
JournalGiornale Italiano di Cardiologia
Volume24
Issue number2
Publication statusPublished - 1994

Fingerprint

Dobutamine
Coronary Balloon Angioplasty
Echocardiography
Stress Echocardiography
Angioplasty
Ischemia
Left Ventricular Dysfunction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

IL TEST ECO-DOBUTAMINA NELLA VALUTAZIONE A BREVE TERMINE DEI RISULTATI DELL'ANGIOPLASTICA CORONARICA. / Lanzarini, L.; Fetiveau, R.; Previtali, M.; Poli, A.; Mussini, A.; Ferrario, M.; Bramucci, E.; Montemartini, C.

In: Giornale Italiano di Cardiologia, Vol. 24, No. 2, 1994, p. 107-114.

Research output: Contribution to journalArticle

@article{f2767d2657e64d8aa0644f724ea88403,
title = "IL TEST ECO-DOBUTAMINA NELLA VALUTAZIONE A BREVE TERMINE DEI RISULTATI DELL'ANGIOPLASTICA CORONARICA",
abstract = "Background. Coronary angioplasty is commonly performed as a means of coronary revascularization, but at present no method has proven to be of definite value in assessing the functional result of a given angiographic procedure. Objectives. The purpose of this study was to evaluate whether dobutamine stress echocardiography can detect a reversal of ischemia-induced left ventricular regional wall motion abnormalities 15 days after an angiographically successful percutaneous transluminal coronary angioplasty (PTCA). Methods. 25 patients underwent dobutamine stress echocardiography 24-48 hours before and 15 days after an elective angiographically successful PTCA. Twelve out of 25 patients (48{\%}) suffered from a previous myocardial infarction. Symptomatic myocardial ischemia was documented before PTCA in 18/25 patients (72{\%}) and asymptomatic ischemia in 7/25 (28{\%}). Dobutamine was infused utilizing incremental steps of 5 mcg/kg/min over 3 minutes, up to a maximal dose of 40 mcg/kg/min. Echocardiographic images were stored on video tape and analyzed in a qualitative manner by two independent and experienced cardiologists without knowledge of the angiographic data. An asynergy score (from 0 = normal to 3 = diskinesia) was calculated using a 14-segment left ventricular model in basal conditions and at peak stress, before and after PTCA. All tests were performed taking the patients off the antianginal therapy. Results. One-vessel coronary artery disease was present in 18/25 (72{\%}) patients, and two-vessel disease in 7/25 (28{\%}) four of these 7 patients underwent PTCA on both involved vessels; mean diameter of the stenosis was 91 ± 6{\%} before PTCA, and was reduced to 22 ± 8{\%} after PTCA. Dobutamine stress echocardiography induced wall motion abnormalities in 24/25 patients before and in 4/25 after PTCA; the frequency of dobutamine-induced wall motion abnormalities significantly decreased from 96{\%} to 12{\%} before and after angioplasty (p <.01). All patients developed regional wall motion abnormalities in the region supplied by the dilated vessel. Wall motion score at peak dobutamine infusion improved from 8.5 ± 4.8 before PTCA to 2.6 ± 4.9 after PTCA (p <.001). There was a significant increase in the rate-pressure product achieved during the test after PTCA (21300 ± 400 bts/min.mmHg) compared to the test performed before PTCA (19000 ± 500 bts/min.mmHg) (p <.05). Dobutamine induced angina in 6/26 patients (24{\%}) and ST-segment changes in 19/25 patients (76{\%}) before PTCA, whereas angina occurred only once after PTCA and ST-segment changes 6 times only after PTCA. No major side effects occurred during dobutamine infusion both before and after PTCA. Conclusions. Our study indicates that dobutamine stress echocardiography is a feasible and safe method that accurately demonstrates an early improvement in stress-induced regional left ventricular dysfunction after an angiogrphically successful coronary angioplasty.",
keywords = "coronary angioplasty, diagnostic technique, dobutamine-stress echocardiography",
author = "L. Lanzarini and R. Fetiveau and M. Previtali and A. Poli and A. Mussini and M. Ferrario and E. Bramucci and C. Montemartini",
year = "1994",
language = "Italian",
volume = "24",
pages = "107--114",
journal = "Giornale Italiano di Cardiologia",
issn = "0046-5968",
publisher = "Societa Italiana di Cardiologia",
number = "2",

}

TY - JOUR

T1 - IL TEST ECO-DOBUTAMINA NELLA VALUTAZIONE A BREVE TERMINE DEI RISULTATI DELL'ANGIOPLASTICA CORONARICA

AU - Lanzarini, L.

AU - Fetiveau, R.

AU - Previtali, M.

AU - Poli, A.

AU - Mussini, A.

AU - Ferrario, M.

AU - Bramucci, E.

AU - Montemartini, C.

PY - 1994

Y1 - 1994

N2 - Background. Coronary angioplasty is commonly performed as a means of coronary revascularization, but at present no method has proven to be of definite value in assessing the functional result of a given angiographic procedure. Objectives. The purpose of this study was to evaluate whether dobutamine stress echocardiography can detect a reversal of ischemia-induced left ventricular regional wall motion abnormalities 15 days after an angiographically successful percutaneous transluminal coronary angioplasty (PTCA). Methods. 25 patients underwent dobutamine stress echocardiography 24-48 hours before and 15 days after an elective angiographically successful PTCA. Twelve out of 25 patients (48%) suffered from a previous myocardial infarction. Symptomatic myocardial ischemia was documented before PTCA in 18/25 patients (72%) and asymptomatic ischemia in 7/25 (28%). Dobutamine was infused utilizing incremental steps of 5 mcg/kg/min over 3 minutes, up to a maximal dose of 40 mcg/kg/min. Echocardiographic images were stored on video tape and analyzed in a qualitative manner by two independent and experienced cardiologists without knowledge of the angiographic data. An asynergy score (from 0 = normal to 3 = diskinesia) was calculated using a 14-segment left ventricular model in basal conditions and at peak stress, before and after PTCA. All tests were performed taking the patients off the antianginal therapy. Results. One-vessel coronary artery disease was present in 18/25 (72%) patients, and two-vessel disease in 7/25 (28%) four of these 7 patients underwent PTCA on both involved vessels; mean diameter of the stenosis was 91 ± 6% before PTCA, and was reduced to 22 ± 8% after PTCA. Dobutamine stress echocardiography induced wall motion abnormalities in 24/25 patients before and in 4/25 after PTCA; the frequency of dobutamine-induced wall motion abnormalities significantly decreased from 96% to 12% before and after angioplasty (p <.01). All patients developed regional wall motion abnormalities in the region supplied by the dilated vessel. Wall motion score at peak dobutamine infusion improved from 8.5 ± 4.8 before PTCA to 2.6 ± 4.9 after PTCA (p <.001). There was a significant increase in the rate-pressure product achieved during the test after PTCA (21300 ± 400 bts/min.mmHg) compared to the test performed before PTCA (19000 ± 500 bts/min.mmHg) (p <.05). Dobutamine induced angina in 6/26 patients (24%) and ST-segment changes in 19/25 patients (76%) before PTCA, whereas angina occurred only once after PTCA and ST-segment changes 6 times only after PTCA. No major side effects occurred during dobutamine infusion both before and after PTCA. Conclusions. Our study indicates that dobutamine stress echocardiography is a feasible and safe method that accurately demonstrates an early improvement in stress-induced regional left ventricular dysfunction after an angiogrphically successful coronary angioplasty.

AB - Background. Coronary angioplasty is commonly performed as a means of coronary revascularization, but at present no method has proven to be of definite value in assessing the functional result of a given angiographic procedure. Objectives. The purpose of this study was to evaluate whether dobutamine stress echocardiography can detect a reversal of ischemia-induced left ventricular regional wall motion abnormalities 15 days after an angiographically successful percutaneous transluminal coronary angioplasty (PTCA). Methods. 25 patients underwent dobutamine stress echocardiography 24-48 hours before and 15 days after an elective angiographically successful PTCA. Twelve out of 25 patients (48%) suffered from a previous myocardial infarction. Symptomatic myocardial ischemia was documented before PTCA in 18/25 patients (72%) and asymptomatic ischemia in 7/25 (28%). Dobutamine was infused utilizing incremental steps of 5 mcg/kg/min over 3 minutes, up to a maximal dose of 40 mcg/kg/min. Echocardiographic images were stored on video tape and analyzed in a qualitative manner by two independent and experienced cardiologists without knowledge of the angiographic data. An asynergy score (from 0 = normal to 3 = diskinesia) was calculated using a 14-segment left ventricular model in basal conditions and at peak stress, before and after PTCA. All tests were performed taking the patients off the antianginal therapy. Results. One-vessel coronary artery disease was present in 18/25 (72%) patients, and two-vessel disease in 7/25 (28%) four of these 7 patients underwent PTCA on both involved vessels; mean diameter of the stenosis was 91 ± 6% before PTCA, and was reduced to 22 ± 8% after PTCA. Dobutamine stress echocardiography induced wall motion abnormalities in 24/25 patients before and in 4/25 after PTCA; the frequency of dobutamine-induced wall motion abnormalities significantly decreased from 96% to 12% before and after angioplasty (p <.01). All patients developed regional wall motion abnormalities in the region supplied by the dilated vessel. Wall motion score at peak dobutamine infusion improved from 8.5 ± 4.8 before PTCA to 2.6 ± 4.9 after PTCA (p <.001). There was a significant increase in the rate-pressure product achieved during the test after PTCA (21300 ± 400 bts/min.mmHg) compared to the test performed before PTCA (19000 ± 500 bts/min.mmHg) (p <.05). Dobutamine induced angina in 6/26 patients (24%) and ST-segment changes in 19/25 patients (76%) before PTCA, whereas angina occurred only once after PTCA and ST-segment changes 6 times only after PTCA. No major side effects occurred during dobutamine infusion both before and after PTCA. Conclusions. Our study indicates that dobutamine stress echocardiography is a feasible and safe method that accurately demonstrates an early improvement in stress-induced regional left ventricular dysfunction after an angiogrphically successful coronary angioplasty.

KW - coronary angioplasty

KW - diagnostic technique

KW - dobutamine-stress echocardiography

UR - http://www.scopus.com/inward/record.url?scp=0028292909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028292909&partnerID=8YFLogxK

M3 - Articolo

C2 - 8013762

AN - SCOPUS:0028292909

VL - 24

SP - 107

EP - 114

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 0046-5968

IS - 2

ER -